
Photo taken from Lea Monteran/X
Mar 8, 2024, 19:03
Lea Monteran: TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis
Lea Monteran, Ph.D. student at Tel Aviv University, shared on X/Twitter:
“I am excited to share our latest work (and Ph.D.’s baby) with Neta Erez on breast cancer bone metastasis, showing how combining TIGIT blockade with MDSC inhibition may be a novel and promising therapeutic strategy to treat bone metastasis. In Cancer Discovery.”
Proceed to the article.
Source: Lea Monteran/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 04:19
Feb 22, 2025, 03:56
Feb 22, 2025, 03:52
Feb 22, 2025, 03:21
Feb 22, 2025, 03:18
Feb 22, 2025, 02:44